These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7022910)

  • 1. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of kidney-graft survival with increased numbers of blood transfusions.
    Opelz G; Terasaki PI
    N Engl J Med; 1978 Oct; 299(15):799-803. PubMed ID: 357971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood transfusions and kidney transplantation: selection or conditioning of recipients?].
    op den Winkel R; Brunner F; Harder F
    Helv Chir Acta; 1980 Jun; 47(1-2):227-30. PubMed ID: 7002876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
    Chia D; Horimi T; Terasaki PI; Hermes M
    Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.
    Fradet Y; Roy R; Lachance JG; Noël R
    Clin Nephrol; 1982 Aug; 18(2):69-73. PubMed ID: 6754190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLR inhibitory activity of pretransplant anti-donor B cell antibodies, and kidney graft survival.
    Lenhard V; Diehm H; Rettwitz W; Dreikorn K
    Proc Eur Dial Transplant Assoc; 1981; 18():433-8. PubMed ID: 6460245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of B and T cell antibodies in kidney transplantation.
    Lenhard V; Rettwitz W; Dreikorn K; Röhl L
    Proc Eur Dial Transplant Assoc; 1980; 17():478-82. PubMed ID: 7017693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survival.
    Fehrman I; Groth CG; Lundgren G; Magnusson G; Möller E
    Transplant Proc; 1979 Mar; 11(1):152-5. PubMed ID: 377622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of peak and current serum panel-reactive antibody on graft survival.
    Premasathian N; Panorchan K; Vongwiwatana A; Pornpong C; Agadmeck S; Vejbaesya S
    Transplant Proc; 2008 Sep; 40(7):2200-1. PubMed ID: 18790191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion and kidney transplantation: effect of small doses of blood on kidney graft function and survival.
    Sirchia G; Mercuriali F; Pizzi C; Rosso di San Secondo VE; Borzini P; Aniasi A
    Transplant Proc; 1982 Jun; 14(2):263-71. PubMed ID: 7051464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destructive and protective effects of antibody on transplants in humans: practical and theoretical considerations.
    Baldwin WM; Paul LC; Claas FH; Daha MR
    Prog Clin Biol Res; 1986; 224():41-67. PubMed ID: 3540995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion and kidney graft survival in Finland.
    Tiilikainen A; Kock B; Kuhlbäck B; Wallenius M
    Scand J Urol Nephrol Suppl; 1977; (42):70-2. PubMed ID: 356227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
    Drannik GN; Driianskaia VE; Montag TS
    Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The beneficial role of blood transfusion and preganancy in the survival of renal allografts].
    Buy-Quang D; Soulillou JP; Fontenaille C; Guimbretière J; Guenel J
    Nouv Presse Med; 1977 Nov; 6(38):3503-7. PubMed ID: 341078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do antilymphocyte antibodies play a role in the rejection of liver transplants in serum-transfused rats?
    Baquerizo A; Pera C; Teramoto K; Cecka J; Kamada N; Busuttil RW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):297-9. PubMed ID: 1990537
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood transfusion and human renal transplantation.
    Grunnet N; Kristiansen J; Rohr N; Birkeland SA; Svendsen V
    Scand J Urol Nephrol Suppl; 1980; 54():60-2. PubMed ID: 7013046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transfusions as "transplantation pretreatment": incidence of immunization against unfractionated lymphocytes, T- and B-lymphocytes.
    Fehrman I; Opelz G
    Scand J Urol Nephrol Suppl; 1981; 64():93-9. PubMed ID: 6755690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.